Correlation Between Urea  and Phosphate Reduction Ratios During Hemodialysis

Authors

  • Maryam Begum Department of Medicine, Combined Military Hospital, Peshawar/National University of Medical Sciences (NUMS) Pakistan
  • Abdul Rehman Arshad Department of Medicine, Combined Military Hospital, Peshawar/National University of Medical Sciences (NUMS) Pakistan

DOI:

https://doi.org/10.51253/pafmj.v75i3.8418

Keywords:

end stage renal disease, hyperphosphatemia, renal dialysis, renal replacement therapy.

Abstract

Objective: To compare the efficacy of serum phosphate and urea removal during hemodialysis.

Study Design:  Correlational Cross-sectional study.

Place and Duration of Study: Combined Military Hospital, Peshawar, Pakistan from Jul to Dec 2020.

Methodology: Adult patients on maintenance hemodialysis for three months or more were selected by non- probability convenience sampling. Exclusion criteria included hemodialysis for acute kidney injury, the initial three sessions of maintenance hemodialysis in patients with end-stage renal disease and patients unwilling for inclusion in the study. All patients had blood samples collected for serum urea and phosphate before and immediately after completion of hemodialysis session using standard technique. Urea and phosphate reduction ratios were calculated and compared by linear regression.

Results: Hemodialysis sessions were monitored in 76 patients, including 54(71.05%) males and 22 (28.95%) females having mean age of 53.38±13.82 years. During the three-and-a-half-hour-long sessions, urea reduction ratio was greater than phosphate reduction ratio (70.14±11.60% vs 53.19±13.17% respectively). There was a moderate statistically significant correlation between the two (r=0.23; p=0.009). The urea reduction ratio was dependent on gender but not on type of vascular access. Phosphate reduction ratio was not dependent on gender or vascular access.

Conclusion: Phosphate reduction is not as effective as urea reduction during hemodialysis. Thus, other modalities are required for better control of serum phosphate levels amongst patients undergoing hemodialysis.

Downloads

Download data is not yet available.

References

Shafi ST, Saleem M, Anjum R, Abdullah W, Shafi T. Refusal of hemodialysis by hospitalized chronic kidney disease patients in Pakistan. Saudi J Kidney Dis Transpl 2018; 29(2): 401-408.

https://doi.org/10.4103/1319-2442.229270

Arshad AR, Khan G, Amjad Z, Butt B, Islam F, Qayyum M, et al. Predicting quality of life in hemodialysis patients. Pak Armed Forces Med J 2019; 69(1): 175-181.

https://www.pafmj.org/PAFMJ/article/view/2518

Mushi L, Marschall P, Fleßa S. The cost of dialysis in low and middle-income countries: a systematic review. BMC Health Serv Res 2015;15:506.

https://doi.org/10.1186/s12913-015-1166-8

Elder GJ, Malik A, Lambert K. Role of dietary phosphate restriction in chronic kidney disease. Nephrology (Carlton) 2018; 23(12): 1107-1115. https://doi.org/10.1111/nep.13188

Kim JS, Hwang HS. Vascular Calcification in Chronic Kidney Disease: Distinct features of pathogenesis and clinical implication. Korean Circ J 2021; 51(12): 961-982.

https://doi.org/10.4070/kcj.2021.0995

Zhang W, Du Q, Xiao J, Bi Z, Yu C, Ye Z et al. Modification and validation of the phosphate removal model: a multicenter study. Kidney Blood Press Res 2021; 46(1): 53-62.

https://doi.org/10.1159/000511375

Wang M, Li H, Liao H, Yu Y, You L, Zhu J, et al. Phosphate removal model: an observational study of low-flux dialyzers in conventional hemodialysis therapy. Hemodial Int 2012; 16(3): 363-376.

https://doi.org/10.1111/j.1542-4758.2012.00678.x

Debowska M, Wojcik-Zaluska A, Ksiazek A, Zaluska W, Waniewski J. Phosphate, urea and creatinine clearances: haemodialysis adequacy assessed by weekly monitoring. Nephrol Dial Transplant 2015; 30(1): 129-136.

https://doi.org/10.1093/ndt/gfu266

Statisticss Kingdom. Regression and ANOVA - Sample Size Calculator. Melbourne: [Internet]. Available at: https://www.statskingdom.com/sample_size_regression.html

Anees M, Hameed F, Mumtaz A, Ibrahim M, Saeed Khan MN. Dialysis-related factors affecting quality of life in patients on hemodialysis. Iran J Kidney Dis 2011; 5(1): 9-14.

Arshad AR, Fahad M, Begum M, Ahmed T, Khan I. Is missing hemodialysis associated with short term morbidity and mortality in end stage renal disease? Ann King Edw Med Univ 2021; 27(4): 531-535.

https://doi.org/10.21649/akemu.v27i4.4886

Abbas M, Saleem S, Rasool Z, Mahmood A, Mansur A. Phosphate clearance in End Stage Kidney Disease patients on Hemodialysis. J Pak Soc Intern Med 2024; 5(4): 729-734.

https://doi.org/10.70302/jpsim.v5i4.2474

Somji SS, Ruggajo P, Moledina S. Adequacy of hemodialysis and its associated factors among patients undergoing chronic hemodialysis in Dar es Salaam, Tanzania. Int J Nephrol 2020; 2020: 9863065. https://doi.org/10.1155/2020/9863065

Rezaiee O, Shahgholian N, Shahidi S. Assessment of hemodialysis adequacy and its relationship with individual and personal factors. Iran J Nurs Midwifery Res 2016; 21(6): 577-582.

https://doi.org/10.4103/1735-9066.197673

Shahdadi H, Balouchi A, Sepehri Z, Rafiemanesh H, Magbri A, Keikhaie F, et al. Factors affecting hemodialysis adequacy in a cohort of Iranian patients with end-stage renal disease. Glob J Health Sci 2016; 8(8): 50-56.

https://doi.org/10.5539/gjhs.v8n8p50

Chand DH, Teo BW, Fatica RA, Brier M; Medical Review Board of The Renal Network, Inc. Influence of vascular access type on outcome measures in patients on maintenance hemodialysis. Nephron Clin Pract 2008; 108(2): c91-8.

https://doi.org/10.1159/000113525

Hannedouche T, Fouque D, Joly D. Complications métaboliques en insuffisance rénale chronique : hyperphosphatémie, hyperkaliémie et anémie [Metabolic complications in chronic kidney disease: hyperphosphatemia, hyperkalemia and anemia]. Nephrol Ther 2018; 14(6S): 6S17-6S25.

https://doi.org/10.1016/s1769-7255(18)30647-3

Elias RM, Alvares VRC, Moysés RMA. Phosphate removal during conventional hemodialysis: a decades-old misconception. Kidney Blood Press Res 2018; 43(1): 110-114.

https://doi.org/10.1159/000487108

Sampaio MS, Ruzany F, Dorigo DM, Suassuna JH. Phosphate mass removal during hemodialysis: a comparison between eKT/V-matched conventional and extended dialysis. Am J Nephrol 2012; 36(2): 121-126.

https://doi.org/10.1159/000338675

Zupančič T, Ponikvar R, Gubenšek J, Buturović-Ponikvar J. Phosphate removal during long nocturnal hemodialysis/hemodiafiltration: a study with total dialysate collection. Ther Apher Dial 2016; 20(3): 267-271.

https://doi.org/10.1111/1744-9987.12435

Downloads

Published

30-06-2025

Issue

Section

Original Articles

How to Cite

1.
Begum M, Arshad AR. Correlation Between Urea  and Phosphate Reduction Ratios During Hemodialysis. Pak Armed Forces Med J [Internet]. 2025 Jun. 30 [cited 2025 Jul. 8];75(3):450-3. Available from: https://pafmj.org/PAFMJ/article/view/8418